Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing

scientific article

Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/ploscb/LimP0THZMX16
P356DOI10.1371/JOURNAL.PCBI.1005135
P8608Fatcat IDrelease_hep7kmhnlzbhhlkezsafr3zwqu
P3181OpenCitations bibliographic resource ID3091151
P932PMC publication ID5055357
P698PubMed publication ID27716836

P50authorHansaim LimQ95990861
Di HeQ95990862
Luke ZhuangQ95990863
P2093author name stringYuan Yao
Lei Xie
Hanghang Tong
Aleksandar Poleksic
Patrick Meng
P2860cites workBLAST+: architecture and applicationsQ21284368
Cytoscape: a software environment for integrated models of biomolecular interaction networksQ24515682
DrugBank: a knowledgebase for drugs, drug actions and drug targetsQ24650300
The ChEMBL bioactivity database: an updateQ27144224
Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?Q27702310
PubChem Substance and Compound databasesQ27942588
An efficient algorithm for large-scale detection of protein familiesQ28131838
Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulenceQ28271536
In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulatorsQ28471679
A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homologyQ28472464
Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitorsQ28475474
Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosisQ28475676
Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of NelfinavirQ28477930
Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor ProfileQ28534336
Neighborhood Regularized Logistic Matrix Factorization for Drug-Target Interaction PredictionQ28550158
Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual DrugsQ28969532
Virtual screening system for finding structurally diverse hits by active learningQ51961602
Scientists in the dark after French clinical trial proves fatal.Q55059540
The cost of new drug discovery and developmentQ84730346
UniProt: a hub for protein informationQ29547457
ZINC: a free tool to discover chemistry for biologyQ29615857
Relating protein pharmacology by ligand chemistryQ29617492
Detecting evolutionary relationships across existing fold space, using sequence order-independent profile-profile alignments.Q30368616
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancerQ30446943
In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naïve Bayes and Parzen-Rosenblatt windowQ30653633
Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assaysQ31143550
Microtubule assembly dynamics: an attractive target for anticancer drugsQ34010820
Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivoQ34149540
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomideQ34437996
Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude miceQ34639817
Anticancer effects of niclosamide in human glioblastoma.Q34889036
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiformeQ35170361
The Comparative Toxicogenomics Database's 10th year anniversary: update 2015.Q35254732
Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft modelQ35538164
A pharmacological organization of G protein–coupled receptorsQ36575957
Improving compound-protein interaction prediction by building up highly credible negative samplesQ36614015
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling.Q38063789
Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?Q38190311
Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinomaQ39123107
Feasibility of Active Machine Learning for Multiclass Compound ClassificationQ40134572
Deep neural nets as a method for quantitative structure-activity relationshipsQ41506565
Unmasking determinants of specificity in the human kinome.Q41950534
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazoleQ43542124
Gaussian interaction profile kernels for predicting drug-target interactionQ45961548
Active learning with support vector machines in the drug discovery process.Q45967032
Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization.Q46766552
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesCytoscapeQ3699942
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectcollaborative filteringQ94702
collaborationQ1145523
P304page(s)e1005135
P577publication date2016-10-01
P1433published inPLOS Computational BiologyQ2635829
P1476titleLarge-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing
P478volume12

Reverse relations

cites work (P2860)
Q102373171A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions
Q89556273ANTENNA, a Multi-Rank, Multi-Layered Recommender System for Inferring Reliable Drug-Gene-Disease Associations: Repurposing Diazoxide as a Targeted Anti-Cancer Therapy
Q92157379Biological representation of chemicals using latent target interaction profile
Q38634659Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors.
Q28468460Correction: Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing
Q92288577Database of adverse events associated with drugs and drug combinations
Q47893147Evidence-Based Precision Oncology with the Cancer Targetome.
Q55291267Exploring Landscape of Drug-Target-Pathway-Side Effect Associations.
Q28817549Improved genome-scale multi-target virtual screening via a novel collaborative filtering approach to cold-start problem
Q52331906Opportunities and obstacles for deep learning in biology and medicine.
Q92803555Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology
Q52591435Realizing drug repositioning by adapting a recommendation system to handle the process
Q39169235Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery
Q91809725Target Gene Prediction of Transcription Factor Using a New Neighborhood-regularized Tri-factorization One-class Collaborative Filtering Algorithm
Q91595000The Route to 'Chemobrain' - Computational probing of neuronal LTP pathway
Q89651597Turning liabilities into opportunities: Off-target based drug repurposing in cancer
Q36369116Water permeation through the internal water pathway in activated GPCR rhodopsin

Search more.